key: cord-0325901-xy69rtw9
authors: Tabtieng, Tate; Lent, Rachel C.; Sanchez, Alvaro Monago; Gaglia, Marta Maria
title: Analysis of caspase-mediated regulation of the cGAS/STING pathway in Kaposi’s sarcoma-associated herpesvirus lytic infection reveals a dramatic cellular heterogeneity in type I interferon responses
date: 2021-05-03
journal: bioRxiv
DOI: 10.1101/2021.05.03.442439
sha: 1444108d389f3d8bbde09f39218b73931bc6431e
doc_id: 325901
cord_uid: xy69rtw9

During the ongoing virus-host arms race, viruses have evolved numerous immune subversion strategies aimed at the production of type I interferons (IFNs)1. This focus on IFN evasion highlights the essentiality of these cytokines in controlling viral infections. Apoptotic caspases have recently emerged as important regulators of type I IFN signaling in both non-infectious contexts and during viral infection2–5. Surprisingly, they promote viral immune evasion despite being widely considered anti-viral from triggering cell death2–5. Indeed, we previously discovered that the AIDS-associated oncogenic gammaherpesvirus Kaposi’s sarcoma-associated herpesvirus (KSHV) exploits caspase-8 activity to suppress the antiviral type I IFN response and promote viral replication5. However, the mechanisms of this novel viral immune evasion strategy are poorly understood, particularly how caspase-8 antagonizes IFN signaling. Here we show that caspase activity inhibits the DNA sensor cGAS6 during KSHV lytic replication to block IFN induction. Furthermore, we use single-cell RNA-sequencing to reveal that the potent antiviral state conferred upon caspase inhibition is mediated by an exceptionally small percentage of infected cells expressing IFN-β, thus uncovering further complexity of IFN regulation during viral infection. Collectively, these results provide insight into multiple levels of type I IFN regulation by the cell and the way in which viruses co-opt them for immune evasion. Unraveling these mechanisms can inform targeted therapeutic strategies for viral infections and reveal cellular mechanisms of regulating interferon signaling in the context of cancer and chronic inflammatory diseases.

During the ongoing virus-host arms race, viruses have evolved numerous immune subversion strategies aimed at the production of type I interferons (IFNs) 1 . This focus on IFN evasion highlights the essentiality of these cytokines in controlling viral infections. Apoptotic caspases have recently emerged as important regulators of type I IFN signaling in both non-infectious contexts and during viral infection [2] [3] [4] [5] . Surprisingly, they promote viral immune evasion despite being widely considered anti-viral from triggering cell death [2] [3] [4] [5] . Indeed, we previously discovered that the AIDS-associated oncogenic gammaherpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV) exploits caspase-8 activity to suppress the antiviral type I IFN response and promote viral replication 5 . However, the mechanisms of this novel viral immune evasion strategy are poorly understood, particularly how caspase-8 antagonizes IFN signaling. Here we show that caspase activity inhibits the DNA sensor cGAS 6 during KSHV lytic replication to block IFN induction. Furthermore, we use single-cell RNA-sequencing to reveal that the potent antiviral state conferred upon caspase inhibition is mediated by an exceptionally small percentage of infected cells expressing IFN-β, thus uncovering further complexity of IFN regulation during viral infection. Collectively, these results provide insight into multiple levels of type I IFN regulation by the cell and the way in which viruses co-opt them for immune evasion. Unraveling these mechanisms can inform targeted therapeutic strategies for viral infections and reveal cellular mechanisms of regulating interferon signaling in the context of cancer and chronic inflammatory diseases.

Upon infection of a host cell, viral nucleic acids are sensed by host cell pattern recognition receptors such as the cytosolic DNA sensor cGAS and RNA sensor RIG-I 7 . These sensors signal through adaptor proteins (STING and MAVS, respectively) and the kinases TBK1 and IKKε to activate the transcription factor IRF3 and trigger induction of type I IFN cytokines 7 .

Type I IFNs in turn signal to both the producing and neighboring cells to express interferon stimulated genes (ISGs) that limit viral replication and infection 8 . As this is a strong antiviral response, all viruses have evolved one or more strategies to block IFN induction 1 . Indeed, KSHV induces minimal type I IFN responses when reactivating from latency 5, 9 , demonstrating it can strongly block this response. While many viral encoded factors directly target the type I IFN response, viruses have also evolved strategies to usurp cellular pathways to counteract immune responses. While apoptotic caspases are canonically thought to be antiviral by facilitating cell death of infected cells, recent studies have demonstrated caspase-dependent inhibition of innate immune signaling during apoptosis and viral infection [2] [3] [4] [5] . Caspase-3 and -7 can directly cleave cGAS, MAVS, and IRF3 to block type I IFN signaling 4 . In addition, we established that KSHV exploits caspase-8 activity to suppress the type I IFN response 5 . While normally KSHV reactivation does not induce a strong type I IFN response, lytically infected cells express and secrete high levels of IFN-β , if caspase-8 is inhibited 5 . KSHV uses this mechanism to promote viral replication while at the same time preventing caspase-mediated cell death 5 . However, it is unclear how caspase-8 enacts this previously undescribed IFN regulatory function.

We previously showed that the type I IFN response that occurs upon caspase inhibition is dependent on TBK1 5 , a kinase that can be activated by several pathogen sensors 7 . To discern which pathway mediates IFN induction and is inhibited by caspase activity during KSHV infection, we knocked down the key adaptor proteins for DNA sensing, STING, and RNA sensing, MAVS (Supp Fig. 1, Fig. 1 ). For these experiments, we used iSLK.219 cells, which are latently infected with recombinant rKSHV.219 that expresses GFP constitutively and RFP under the control of a KSHV lytic promoter 10 . These cells also express an exogenous copy of the KSHV master lytic regulator RTA under a doxycycline inducible promoter, so that reactivation of the viral lytic replication cycle can be induced by doxycycline treatment 10 . Knockdown of STING and MAVS effectively and specifically attenuated IFN-β induction through their respective signaling pathways after stimulation with plasmid DNA or poly(I:C) (Supp. Fig. 1B , D). Importantly, IFN-β induction upon caspase inhibition was severely reduced with STING depletion, suggesting that caspase activity targets STING-dependent type I IFN signaling during KSHV replication (Fig. 1A) . Moreover, upon STING knock-down, caspase inhibitors no longer caused a reduction in KSHV replication, which we previously showed is a result of type I IFN induction 5 (Fig.1B) . MAVS knockdown also partially reduced IFN-β expression upon caspase inhibition (Fig.1A) , but it also substantially decreased the expression of the viral mRNA ORF37 even in the absence of caspase inhibitors (Fig.1B) , suggesting that the reduced IFN-β induction in this case may be due to lower levels of KSHV reactivation in the absence of MAVS.

To confirm that caspase activity predominantly targets IFN-β induction through the DNA sensing pathway, we tested two DNA sensors that act upstream of STING and were previously reported to sense KSHV, cGAS 9,11,12 and the nuclear localized sensor IFI16 13 . Knockdown of cGAS, but not IFI16, reduced IFN-β induction upon caspase inhibition (Fig.1C ). As expected from the effects on IFN-β induction and similar to STING knockdown, cGAS knockdown also prevented the inhibition in ORF37 expression mediated by caspase inhibition (Fig.1D) , suggesting it blocked IFN-β secretion and the consequent reduction in viral replication. In contrast, IFI16 knockdown did not hinder this pro-viral caspase function ( Fig.1C-D) . Consistent with the effects of cGAS knockdown, we also found that pharmacological inhibition of cGAS with RU.521 reduced IFN-β (Fig. 1F ) and ISG15 (Supp. Fig. 2A ) induction upon caspase inhibition. These findings suggest that caspase activity targets the cGAS-STING DNA sensing pathway during KSHV lytic replication.

To corroborate these results, we also tested whether there was differential activation of the cGAS/STING pathway in the presence vs. absence of caspase activity. After binding DNA, cGAS synthesizes the cyclic dinucleotide 2'3'-cGAMP, which in turn binds and activates STING 14 . 2'3'-cGAMP levels were increased upon caspase inhibition and were reduced by treatment with a cGAS inhibitor (Fig.1G ). We also observed increased phosphorylation of the downstream proteins STING, TBK1, and IRF3, which indicates that they are activated upon caspase inhibition (Fig.1H ). Taken together with our results from the knockdown experiments, these findings identify the target of caspases as a component or regulator of the cGAS/STING pathway that acts to promote activation or activity of cGAS.

We considered the possibility that the target was cGAS itself, as one report suggests that caspase-3 and -7 can cut cGAS during apoptosis and other viral infections 4 . However, we do not detect an overall reduction in cGAS levels or cGAS cleavage fragments during lytic reactivation ( Fig. 1E) . It is thus possible that caspases inhibit cGAS activity by targeting a key regulatory factor that modulates cGAS activity.

To determine if caspases also suppress the cGAS/STING pathway in a cell type that is physiologically relevant for KSHV infection and tumorigenesis, we examined the activity of caspases in BC3 cells, a KSHV-infected B cell line derived from a primary effusion lymphoma (PEL) patient. Caspase-8 was also activated upon lytic reactivation of BC3 cells ( Fig. 2A) .

Moreover, caspase inhibition increased expression of both IFN-β and several ISGs (Fig. 2B-D) , and increased IRF3 phosphorylation (Fig. 2F) . Consistent with what we observed in iSLK.219 cells, caspase inhibition potentiated 2'3'-cGAMP production in lytically reactivated BC3 cells (Fig. 2E) . Moreover, inhibition of cGAS with RU.521 reduced the induction of IFN-β (Fig. 2G) and, to some extent, ISG15 (Supp Fig.2B ), as well as IRF3 phosphorylation (Fig. 2F) . These results strengthen our conclusion that caspases have a major role in inhibiting cGAS activity or activation to block IFN induction during KSHV lytic infection. Supp. Fig. 3E ,F) and these corresponded to clusters that only appeared in the lytic samples ( Fig.   3B ,C). We further analyzed the type of genes that were seen in the different clusters in the lytic+vehicle sample, and saw that cells in only one cluster, cluster 12, appeared to have more than 25% KSHV reads and a substantial signal for late genes (Fig. 3E-G) . Because our scRNAseq is directed at the 3' end of RNAs and many mRNAs in KSHV have the same 3' end 17,18 , we were not able to conclusively discern expression of all the genes. However, analysis of individual genes, as well as the KSHV.219 encoded GFP, RFP and puromycin (PAC) reporters agrees with the general picture obtained from percentage reads, with most clusters showing some lytic gene expression and only a few substantial lytic cycle reactivation (Fig. 3E) .

Moreover, we note that some of the clusters that expressed lytic genes did not express high levels of RFP (cluster 0, for example, Fig. 3E ). Furthermore, analysis of the cell cycle status of the cells indicated that most of the cells were in G1, including cells in clusters with high levels of lytic genes, but that some of the clusters were enriched in cells in S or G2/M phase (Supp. Fig. 3G ).

Because KSHV lytic genes are expressed in several waves, termed early lytic, delayed early and late [19] [20] [21] , we roughly categorized the clusters based on the pattern of lytic gene expression, as well as the cell cycle stage and the expression of IFNs. We classified clusters as "uninfected", "latent", "latent (diving)", "lytic (early)", "lytic (intermediate)", "lytic (late)", "lytic (early) and IFN+" (Fig. 3E, 3H ). Figure 3H shows how the different clusters expanded and contracted in each sample. Addition of the caspase inhibitors reduced the percentage of cells in lytic clusters, an effect that was largely rescued by inhibition of paracrine IFN signaling with anti-IFN antibodies (Fig. 3H ). Overall, these data confirm the wide variability in stage of reactivation of iSLK.219 cells and reveal that the RFP signal in iSLK.219 cells may underestimate the cells that are expressing lytic genes. Moreover, they recapitulate our bulk level findings on KSHV replication upon caspase inhibition.

An outstanding question from our bulk analysis was the source of the IFN-β in the caspase inhibitor treated samples, although we hypothesized that the lytically infected cells were producing it. Surprisingly, we found that only 3.8% of the cells in the caspase inhibitor treated samples expressed type I IFNs, particularly IFN-β, and that these were concentrated in clusters 9 and 11, which only appeared in the +IDN-6556 samples (Fig. 4B) . None of the cells expressed IFN-αs. Nonetheless, the IFN-β coming from these cells was sufficient to elicit a strong response in the entire population of cells, as indicated by the expression of interferon stimulated genes (ISGs) (Fig. 4C) . Moreover, as we previously showed in bulk analysis, the type I IFN signaling reduced viral replication and gene expression across the population (Fig.3C , 4D-E). We examined the possibility that only a subset of cells makes IFN-β due to differential expression of viral genes. together with IRF3 7 . In addition, the gene whose expression best correlated with IFN-β+ was RHEBL1, a little-studied regulator of the NF-κB signaling pathway 23 . We also found increased phosphorylation of NF-κB and increased NF-κB levels in lytic cells treated with IDN-6556,

showing that caspase activity also modulates NF-κB activation (Fig. 4H) . It is thus possible that high NF-κB expression is needed to induce IFN in these cells. To ensure that the variability in IFN-β induction is not an artifact of a limit of detection by scRNAseq we constructed a cell line that expresses the TagBFP protein under the control of the IFN-β promoter. When the lytic cycle was induced in these cells concomitantly with caspase inhibitor treatment, we found that ~1% of the cells became TagBFP+ (Fig. 4I) . The percentage was similar among RFP positive and negative cells, which is consistent with our scRNAseq results. Overall, these data show that only a few cells induce IFNs even under caspase inhibition.

Collectively, this study reveals novel mechanistic insight into multiple levels of type I IFN regulation during KSHV infection. The cGAS/STING pathway has emerged in recent years as a crucial component of the innate immune response to DNA viruses and various other pathogens 6 . This is highlighted by the multitude of strategies employed by pathogens 24 , including herpesviruses 25 , to disrupt the cGAS/STING pathway at multiple levels. While this immunosuppression is often driven by viral encoded proteins, we have uncovered an intriguing mechanism in KSHV infection, which involves the hijacking of a host cell component, caspase-8, to subvert immune activation and viral clearance. While caspase-3 has been described to directly target cGAS in an apoptotic setting and some viral infections 4 , caspase-8 activity predominantly mediates the type I IFN suppression observed in KSHV infected cells without triggering apoptosis, and caspase-3 activity is dispensable 5 . These observations in conjunction with the current study suggest an unexpected type I IFN regulatory function of non-apoptotic caspase-8 activity mediated by targeting the cGAS/STING pathway. Caspase-8 is an attractive therapeutic target that could be exploited to potentiate cGAS/STING-mediated immune responses for viral clearance. This could have far reaching implications for other pathologies, as regulation of the cGAS/STING pathway is fundamental in various inflammatory diseases and in tumor immunity 26, 27 , and thus is a current focus of intensive drug discovery research efforts.

The notable cellular heterogeneity in type I IFN production reveals an additional layer of complexity and regulation of innate immune responses during KSHV infection. We detect an exceptionally small fraction of IFN-β+ cells upon caspase inhibitor treatment (< 5%, Fig. 4B ).

Remarkably, this small IFN-β+ cell population still induces a robust IFN response in the population (Fig. 4C) . On a practical level, the high heterogeneity in IFN-β expression complicates our analysis of caspase-8 regulation of cGAS. It is possible that the upstream portions of the pathway (i.e. cGAS) are also only active in the IFN-β+ cells, and that cell sorting may be needed to detect differences in the levels of the direct target(s) of caspase-8 in IFN regulation. Alternatively, it is possible that only a subset of the cells in which the IFN induction pathway is activated end up expressing IFN-β. In support of this idea, we were able to easily detect phosphorylation of many of the components of the IFN induction pathway using bulk analysis (Figs. 1H, 2F, 4H ).

Other studies have also showed a small number of cells that respond to infection in a population in a number of other viruses 22, [28] [29] [30] [31] [32] [33] . Interestingly, several of these studies investigated infections in immune cell types and fibroblasts and saw higher percentages of responding cells (10-30%) 22, 28, 29 . In contrast, iSLK.219 cells are of epithelial origin 34 . Epithelial cells are often the first exposed to invading pathogens and mount responses that alert and prime surrounding cells to counteract viral spread. Therefore, it is possible that epithelial cell responsiveness is even more tightly regulated to prevent inadvertent activation of the pathway. Consistent with this idea, influenza A virus and SARS coronavirus 2 infection of epithelial cells also elicit responses in a small minority of cells [30] [31] [32] .

It is unclear what the source of the heterogeneity is in KSHV-infected cells. Viral gene expression, and in particular in viral immune regulators, is often considered the reason for limited type I IFN responses 32 . However, we find that IFN-β+ have a similar expression pattern as cells that do not make IFNs (Fig. 4D,E) . While we cannot exclude the possibility that one specific gene is responsible for the difference, especially since we do not reliably detect all viral genes, these results suggest that inherent differences in the cells govern the heterogeneity.

Stochasticity in gene expression, which is common among cytokines, has also been proposed as driver of type I IFN expression heterogeneity. Zhao et al. suggested some of this stochasticity may be epigenetically encoded 22 , reducing the number of cells that are able to express type I IFN, perhaps to prevent over-activation and inflammation. Paracrine IFN signaling is also thought to influence and modulate heterogeneity 33 

All cells were cultured at 37 °C and 5% CO 2 conditions. iSLK.219, iSLK.219-IFNBp-BFP, iSLK.RTA 10 For cGAS knockdowns, the reverse transfection process was done twice, once 2 days prior to induction and a second time on the day of lytic cycle induction. All siRNAs were obtained from Life Technologies/Thermo Fisher.

For RNA analysis, iSLK.219 cells were seeded at a density of 33,000 cells per well in a 24-well plate, and the lytic cycle was induced by the addition of doxycycline (1 μ g/ml). RNA HRP-conjugated donkey anti-goat IgG (1:5,000 in 0.5% milk in PBST) was purchased from Santa Cruz Biotechnology. All membranes were exposed using Pierce ECL Western blotting substrate (Thermo Fisher) and imaged with a Syngene G:Box Chemi XT4 gel doc system. Raw sequencing data were processed using the 10X Genomics CellRanger (3.0.0) software.

Reads were aligned to a reference genome containing the human genome (GRCh38), the KSHV genome (GQ994935.1) and the additional sequence of the RFP-GFP insertion cassette. This third reference was added because the GQ994935.1 reference genome corresponds to the KSHV BAC16 genome, whereas our cells contain the rKSHV.219 virus. A full reference for rKSHV.219 is not available. We thus amplified the missing region and sequenced it using Sanger sequencing. Integration and clustering analyses were done in R version 3.6.1 using the Seurat package (version 3.1.1.9021) 15, 16 . Cell cycle analysis was done according Tirosh et al. 37 .

All statistical analysis was performed using GraphPad Prism version 8. 

Ten Strategies of Interferon Evasion by Viruses

Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production

Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA

Apoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3

Caspase-Dependent Suppression of Type I Interferon Signaling Promotes Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication

The cGAS-cGAMP-STING Pathway of Cytosolic DNA Sensing and Signaling

Innate immune sensing and signaling of cytosolic nucleic acids

Interferon-stimulated genes: roles in viral pathogenesis

Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS

Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction

Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses

Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein

IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection

Cyclic GMP-AMP as an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA

Spatial reconstruction of single-cell gene expression data

Integrating single-cell transcriptomic data across different conditions, technologies, and species

KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features

A Viral Genome Landscape of RNA Polyadenylation from KSHV Latent to Lytic Infection

Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Gene Expression as Revealed by DNA Arrays

Dissection of the Kaposi's Sarcoma-Associated Herpesvirus Gene Expression Program by Using the Viral DNA Replication Inhibitor Cidofovir

Quantitative Proteomics Analysis of Lytic KSHV Infection in Human Endothelial Cells Reveals Targets of Viral Immune Modulation

Stochastic Expression of the Interferon-β Gene

Identification and Characterization of RHEBL1, a Novel Member of Ras Family, which Activates Transcriptional Activities of NF-Kappa B

Conserved strategies for pathogen evasion of cGAS-STING immunity

Evasion of Intracellular DNA Sensing by Human Herpesviruses

Regulation and inhibition of the DNA sensor cGAS

Molecular mechanisms and cellular functions of cGAS-STING signalling

Single-cell analysis shows that paracrine signaling by first responder cells shapes the interferon-β response to viral infection

Multi-layered stochasticity and paracrine signal propagation shape the type-I interferon response

Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium

Single cell heterogeneity in influenza A virus gene expression shapes the innate antiviral response to infection

Visualizing the Beta Interferon Response in Mice during Infection with Influenza A Viruses Expressing or Lacking Nonstructural Protein 1

Single-cell analysis reveals that stochasticity and paracrine signaling control interferon-alpha production by plasmacytoid dendritic cells

Kaposi's sarcoma-derived cell line SLK is not of endothelial origin, but is a contaminant from a known renal carcinoma cell line

The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1

A Third-Generation Lentivirus Vector with a Conditional Packaging System

Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq

We thank members of the Gaglia laboratory for suggestion and feedback. This work was supported by American Cancer Society grant 131320-RSG-17-189-01-MPC to MMG. TT was supported by the Tufts Collaborative Cancer Biology Award. RCL is supported by NIH training grant T32 GM007310.